Cargando…

Clinically relevant drug–drug interactions among elderly people with dementia

PURPOSE: Increased numbers of drugs and changes in pharmacokinetic and pharmacodynamic parameters among elderly people contribute to increased prevalence of adverse drug reactions. Drug–drug interactions (DDIs) are an important reason for admission to hospital and elderly people with dementia are pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sönnerstam, Eva, Sjölander, Maria, Lövheim, Hugo, Gustafsson, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132551/ https://www.ncbi.nlm.nih.gov/pubmed/29967921 http://dx.doi.org/10.1007/s00228-018-2514-5

Ejemplares similares

Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries
por: Kindstedt, Jonas, et al.
Publicado: (2021)

An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
por: Sönnerstam, Eva, et al.
Publicado: (2017)

Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013
por: Hemmingsson, Eva-Stina, et al.
Publicado: (2017)

Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
por: Norberg, Helena, et al.
Publicado: (2022)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study
por: Bakken, Marit Stordal, et al.
Publicado: (2014)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
por: Gatti, Milo, et al.
Publicado: (2020)

Drug interaction alerts in older primary care patients, and related medically justified actions
por: Tukukino, Carina, et al.
Publicado: (2022)

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020)

Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
por: Wolgast, Emelie, et al.
Publicado: (2017)

Clinical relevance of the STOPP/START criteria in hip fracture patients
por: Lönnbro, Johan, et al.
Publicado: (2017)

Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older people
por: Pazan, Farhad, et al.
Publicado: (2022)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study
por: Rausch, Christian, et al.
Publicado: (2017)

Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries
por: Karlstad, Øystein, et al.
Publicado: (2016)

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?
por: De Francia, Silvia, et al.
Publicado: (2022)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Non-persistence to antihypertensive drug therapy in Lithuania
por: Treciokiene, Indre, et al.
Publicado: (2022)

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
por: Reppe, Linda Amundstuen, et al.
Publicado: (2014)

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
por: Scuteri, Damiana, et al.
Publicado: (2020)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Aggregation and analysis of indication-symptom relationships for drugs approved in the USA
por: Punyala, Ananth, et al.
Publicado: (2020)

Clinical relevance of potentially inappropriate medications and potential prescribing omissions according to explicit criteria—a validation study
por: Parodi López, Naldy, et al.
Publicado: (2022)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Drug utilisation in neonatal units in England and Wales: a national cohort study
por: Al-Turkait, Asma, et al.
Publicado: (2022)

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
por: Rückert-Eheberg, Ina-Maria, et al.
Publicado: (2021)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bi33ghkmlscmuu045sdu7etehr